Literature DB >> 21873159

Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.

Toshiyuki Tsunoda1, Yasuo Takashima, Yasuhiro Yoshida, Keiko Doi, Yoko Tanaka, Takahiro Fujimoto, Takashi Machida, Takeharu Ota, Midori Koyanagi, Masahide Kuroki, Takehiko Sasazuki, Senji Shirasawa.   

Abstract

BACKGROUND: Oncogenic KRAS plays several key roles in a three-dimensional (3D) colonic-crypt model. However, miRNA expression regulated by oncogenic KRAS in this model is still elusive.
MATERIALS AND METHODS: The differential expression of 105 cancer-related microRNAs was examined and compared in HCT116 cells and HKe3 cells (HCT116 cells in which mutated KRAS allele was deleted) in 3D culture. HKe3 cells stably overexpressing oncogenic KRAS and the public datasets for microRNA expression analysis of colorectal cancer were further examined.
RESULTS: The increased expression of miR-200c, miR-221 and miR-222 were observed exclusively in 3D culture, but not in the two-dimensional culture. These microRNAs were regulated by oncogenic KRAS and were significantly overexpressed in human colorectal tumor specimens. Of note, the protein expression level of Phosphatase and tensin homolog (PTEN), a putative target of miR-221/222 cluster, was reduced under the control of oncogenic KRAS in a 3D-specific manner.
CONCLUSION: Oncogenic KRAS regulates 3D-specific molecules, possibly being associated with colorectal tumor development in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873159

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells.

Authors:  Shadan Ali; Raagini Suresh; Sanjeev Banerjee; Bin Bao; Zhihong Xu; Jeremy Wilson; Philip A Philip; Minoti Apte; Fazlul H Sarkar
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.

Authors:  Mi Kyeong Kim; Sang Bong Jung; Jong-Sik Kim; Mee Sook Roh; Ji Hyun Lee; Eun Hee Lee; Hyoun Wook Lee
Journal:  Virchows Arch       Date:  2014-08-16       Impact factor: 4.064

3.  Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer.

Authors:  Zahra Heydari; Mahdi Rahaie; Ali Mohammad Alizadeh; Shahram Agah; Solmaz Khalighfard; Sahar Bahmani
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

Review 4.  Interplay between K-RAS and miRNAs.

Authors:  Bing Shui; Gaspare La Rocca; Andrea Ventura; Kevin M Haigis
Journal:  Trends Cancer       Date:  2022-01-31

5.  microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.

Authors:  T O Yau; C W Wu; Y Dong; C-M Tang; S S M Ng; F K L Chan; J J Y Sung; J Yu
Journal:  Br J Cancer       Date:  2014-09-18       Impact factor: 7.640

6.  miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.

Authors:  Jing Li; Qiang Tan; Mingxia Yan; Lei Liu; Hechun Lin; Fangyu Zhao; Guoliang Bao; Hanwei Kong; Chao Ge; Fanglin Zhang; Tao Yu; Jinjun Li; Xianghuo He; Ming Yao
Journal:  Mol Cancer       Date:  2014-07-06       Impact factor: 27.401

7.  Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.

Authors:  Toshiyuki Tsunoda; Takeharu Ota; Takahiro Fujimoto; Keiko Doi; Yoko Tanaka; Yasuhiro Yoshida; Masahiro Ogawa; Hiroshi Matsuzaki; Masato Hamabashiri; Darren R Tyson; Masahide Kuroki; Shingo Miyamoto; Senji Shirasawa
Journal:  Mol Cancer       Date:  2012-07-25       Impact factor: 27.401

Review 8.  Role of MicroRNAs-221/222 in Digestive Systems.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki
Journal:  J Clin Med       Date:  2015-08-06       Impact factor: 4.241

9.  Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Erica Wolff; Michael D Hoffman; Daniel F Pellatt; John R Stevens; Roger K Wolff
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

10.  MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer.

Authors:  Heli Gao; Xuejing Cong; Jianfeng Zhou; Mei Guan
Journal:  Cancer Cell Int       Date:  2017-08-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.